{
    "code": "02023428",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023428",
    "time": "2017-01-13 03:02:57",
    "許可證字號": "衛署藥輸字第023428號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/05\/06",
    "發證日期": "91\/05\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202342806",
    "中文品名": "威博雋持續性藥效錠",
    "英文品名": "WELLBUTRIN SUSTAINED-RELEASE TABLETS 150MG",
    "適應症": "憂鬱症、治療尼古丁依賴性，作為戒煙之輔助。",
    "劑型": "121持續性藥效錠",
    "包裝": "2-1000錠盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "BUPROPIONHYDROCHLORIDE"
    ],
    "限制項目": "02輸　入 52依本署七七公告於國內進行臨床試驗且核定為新藥",
    "申請商名稱": "0901801100  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F460295100  GLAXOSMITHKLINE LLC.",
        "製造廠廠址": "1011 NORTH ARENDELL AVENUE,ZEBULON,NC 27597,USA",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "F350010000  GLAXOSMITHKLINE PHARMACEUTICALS S.A.",
            "製造廠廠址": "UL. GRUNWALDZKA 189, 60-322 POZNAN, POLAND",
            "製造廠公司地址": "",
            "製造廠國別": "POLAND",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9250001110",
            "成分名稱": "BUPROPION HYDROCHLORIDE",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "0202342800001-105-12-15.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023428&Seq=002&Type=9"
        },
        {
            "title": "020234280001-105-06-15.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023428&Seq=001&Type=9"
        },
        {
            "title": "020234280004-105-12-15.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023428&Seq=005&Type=8"
        },
        {
            "title": "020234280003-105-12-15.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023428&Seq=004&Type=8"
        },
        {
            "title": "Wellbutrin SR Tab F824-001-02_10000000133842-104-09-30(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023428&Seq=003&Type=8"
        },
        {
            "title": "Wellbutrin SR Tab M824-001-06_10000000133841-104-09-30(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023428&Seq=002&Type=8"
        }
    ]
}